Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
38 hedge funds and large institutions have $643K invested in Chembio diagnostics, Inc. in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.
183% more call options, than puts
Call options by funds: $17K | Put options by funds: $6K
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
44% less capital invested
Capital invested by funds: $1.15M → $643K (-$511K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$24.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17K |
| 3 |
Renaissance Technologies
New York
|
+$6.82K |
| 4 |
Jane Street
New York
|
+$6.49K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$4.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$69K |
| 2 |
RA
Royce & Associates
New York
|
-$49K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$22.4K |
| 4 |
HF
HRT Financial
New York
|
-$12K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$10K |
CEMI Hedge Fund Activity: Q4 2022 in Review
38 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2022, worth a combined $643K — down 44% from $1.15M a quarter earlier.
Fund positioning in CEMI was balanced in Q4 2022: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 11 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $24.1K. The largest seller was Millennium Management, exiting entirely with an estimated $69K sold.
- 38 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $643K of Chembio diagnostics, Inc. stock for Q4 2022, down 44% quarter-over-quarter.
- 7 funds opened new Chembio diagnostics, Inc. positions in Q4 2022 and 7 closed out, a net change of 0 holders.
- The largest Chembio diagnostics, Inc. buyer in Q4 2022 was Virtu Financial, an estimated $24.1K added.
- The largest Chembio diagnostics, Inc. seller in Q4 2022 was Millennium Management, an estimated $69K sold.
Based on aggregated 13F filings for Q4 2022.